Advertisement

Picture Fairtec GmbH Worldwide Event Solutions 600x60px
Document › Details

Biodesix, Inc.. (8/29/12). "Press Release: Biodesix Closes Series D Financing". Boulder, CO.

Organisation Organisation Biodesix Inc.
Products Product VeriStrat® test
  Product 2 ProTS® technology
Index term Index term Biodesix–SEVERAL: investment, 201208 financing round Series D extension $12m
     


Biodesix, Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, has closed on a $12 million extension to its Series D financing. The new capital will support commercialization activities for the Company's first product VeriStrat®, a blood-based test that helps physicians guide treatment for patients with non-small cell lung cancer (NSCLC). Funding will also support clinical validation studies, product development, and ongoing collaborations with a number of biotechnology and pharmaceutical companies.


About Biodesix

Biodesix is a fully integrated molecular diagnostics company advancing the development of products for personalized medicine. Biodesix developed, validated and commercialized VeriStrat®, a serum proteomic test currently available to help physicians guide therapy for patients with advanced non-small cell lung cancer. Samples are processed in Biodesix' CLIA -certified laboratory and results are typically reported within 72 hours of sample shipment. VeriStrat is based on ProTS®, proprietary technology which harnesses the power of mass spectrometry and enables the discovery of specific molecular profiles that characterize a patient's condition or likely outcome in response to therapy. Biodesix collaborates with clinical investigators to address critical clinical questions, and partners with biotechnology and pharmaceutical companies to develop diagnostics to select patients most likely to benefit from novel therapies. For more information about Biodesix, please visit www.Biodesix.com.

   
Record changed: 2016-03-22

Advertisement

Picture Fairtec GmbH We Optimise the ROI of Your Event 600x60px

More documents for Biodesix Inc.


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Cell & Gene Exchange 2017 Washington DC USA May 120x180px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px